Park YM - Search Results

1

Gram-negative bacteria and their lipopolysaccharides in Alzheimer's disease: pathologic roles and therapeutic implications.

Kim HS, Kim S, Shin SJ, Park YH, Nam Y, Kim CW, Lee KW, Kim SM, Jung ID, Yang HD, Park YM, Moon M. Kim HS, et al. Among authors: park yh, park ym. Transl Neurodegener. 2021 Dec 7;10(1):49. doi: 10.1186/s40035-021-00273-y. Transl Neurodegener. 2021. PMID: 34876226 Free PMC article. Review.

2

Myostatin inhibitor YK11 as a preventative health supplement for bacterial sepsis.

Lee SJ, Gharbi A, Shin JE, Jung ID, Park YM. Lee SJ, et al. Among authors: park ym. Biochem Biophys Res Commun. 2021 Mar 5;543:1-7. doi: 10.1016/j.bbrc.2021.01.030. Epub 2021 Feb 12. Biochem Biophys Res Commun. 2021. PMID: 33588136 Free article.

3

IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria.

Lee SJ, You JS, Gharbi A, Kim YJ, Lee MS, Kim DH, Lee KW, Jung ID, Park YM. Lee SJ, et al. Among authors: park ym. Sci Rep. 2021 Feb 3;11(1):2942. doi: 10.1038/s41598-021-82377-z. Sci Rep. 2021. PMID: 33536477 Free PMC article.

4

IOX1 impedes host inflammation in imiquimod-triggered psoriasis.

Shin JE, Lee SJ, Gharbi A, Jung ID, Park YM. Shin JE, et al. Among authors: park ym. Heliyon. 2021 Nov 19;7(11):e08433. doi: 10.1016/j.heliyon.2021.e08433. eCollection 2021 Nov. Heliyon. 2021. PMID: 34877426 Free PMC article.

5

Platelet-activating Factor Mediates Endotoxin Tolerance by Regulating Indoleamine 2,3-Dioxygenase-dependent Expression of the Suppressor of Cytokine Signaling 3.

Noh KT, Jung ID, Cha GS, Han MK, Park YM. Noh KT, et al. Among authors: park ym. J Biol Chem. 2017 Feb 24;292(8):3290-3298. doi: 10.1074/jbc.M116.764464. Epub 2017 Jan 11. J Biol Chem. 2017. PMID: 28077574 Free PMC article.

6

Repositioning of the antipsychotic drug TFP for sepsis treatment.

Park JH, Park HJ, Lee SE, Kim YS, Jang GY, Han HD, Jung ID, Shin KC, Bae YM, Kang TH, Park YM. Park JH, et al. Among authors: park ym, park hj. J Mol Med (Berl). 2019 May;97(5):647-658. doi: 10.1007/s00109-019-01762-4. Epub 2019 Mar 8. J Mol Med (Berl). 2019. PMID: 30848296 Free PMC article.

7

Drug repositioning of TANK-binding kinase 1 inhibitor CYT387 as an alternative for the treatment of Gram-negative bacterial sepsis.

Lee SJ, Gharbi A, You JS, Han HD, Kang TH, Hong SH, Park WS, Jung ID, Park YM. Lee SJ, et al. Among authors: park ws, park ym. Int Immunopharmacol. 2019 Aug;73:482-490. doi: 10.1016/j.intimp.2019.05.051. Epub 2019 Jun 4. Int Immunopharmacol. 2019. PMID: 31173970

8

Phloretin as a Potent Natural TLR2/1 Inhibitor Suppresses TLR2-Induced Inflammation.

Kim J, Durai P, Jeon D, Jung ID, Lee SJ, Park YM, Kim Y. Kim J, et al. Among authors: park ym. Nutrients. 2018 Jul 5;10(7):868. doi: 10.3390/nu10070868. Nutrients. 2018. PMID: 29976865 Free PMC article.

9

Nanoparticle-based vaccine delivery for cancer immunotherapy.

Park YM, Lee SJ, Kim YS, Lee MH, Cha GS, Jung ID, Kang TH, Han HD. Park YM, et al. Immune Netw. 2013 Oct;13(5):177-83. doi: 10.4110/in.2013.13.5.177. Epub 2013 Oct 26. Immune Netw. 2013. PMID: 24198742 Free PMC article. Review.

10

Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.

Noh KT, Son KH, Jung ID, Kang TH, Choi CH, Park YM. Noh KT, et al. Among authors: park ym. J Biol Chem. 2015 May 8;290(19):12394-402. doi: 10.1074/jbc.M114.628578. Epub 2015 Mar 26. J Biol Chem. 2015. PMID: 25814664 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,739 results

Search Page